Trial · NCT00661895
Black Education and Treatment of Hypertension (BEAT HTN)
NCT00661895, Phase 4, Completed, Creighton University; results first posted 2012-12-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Black Education and Treatment of Hypertension (BEAT HTN). Trials, record NCT00661895. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00661895
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Black Education and Treatment of Hypertension (BEAT HTN)
- NCT number
- NCT00661895
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 99 participants, actual
- Lead sponsor
- Creighton University
- Conditions
- Hypertension
- Interventions
- Hydrochlorothiazide, Lisinopril, Lisinopril and Hydrochlorothiazide, Nifedipine XL, Metoprolol tartrate, Atenolol, Valsartan, Doxazosin, Clonidine, Hydralazine, Metoprolol succinate, Amlodipine
- First posted
- 2008-04-21
- Last updated
- 2012-12-04
- Results first posted
- 2012-12-04
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Subjects Achieving Blood Pressure Goals | 3 month intervals | Percentage of subjects who achieved JNC-VII defined blood pressure goals. |
| Secondary | New Onset Diabetes Mellitus | 3 month intervals |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Percentage of Subjects Achieving Blood Pressure Goals | 3 month intervals | percentage of participants | NUMBER | |
| SECONDARY | New Onset Diabetes Mellitus | 3 month intervals |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Subjects Achieving Blood Pressure Goals | Intervention | 81 | percentage of participants | ||
| Percentage of Subjects Achieving Blood Pressure Goals | Control | 57 | percentage of participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Intervention | 49 | |
| Overall Study | STARTED | Control | 50 | |
| Overall Study | COMPLETED | Intervention | 49 | |
| Overall Study | COMPLETED | Control | 50 | |
| Overall Study | NOT COMPLETED | Intervention | 0 | |
| Overall Study | NOT COMPLETED | Control | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intervention | ||
| Total, all-cause mortality | Control | ||
| Total, other adverse events | Intervention | 0 | 49 |
| Total, other adverse events | Control | 0 | 50 |
| Total, serious adverse events | Intervention | 0 | 49 |
| Total, serious adverse events | Control | 0 | 50 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Intervention vs Control: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00661895
GET https://conductscience.org/api/trials/v1/NCT00661895/registered